Výsledky vyhledávání - "Chioma Onyiah"

Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial

Autor: Kim A, Reiss, Rosemarie, Mick, Ursina, Teitelbaum, Mark, O'Hara, Charles, Schneider, Ryan, Massa, Thomas, Karasic, Rashmi, Tondon, Chioma, Onyiah, Mary Kate, Gosselin, Alyssa, Donze, Susan M, Domchek, Robert H, Vonderheide

Publikováno v: Lancet Oncol

Establishing alternatives to lifelong chemotherapy for patients with advanced pancreatic cancer has been proposed to address chemotherapy resistance and cumulative toxicity. Poly(ADP-ribose) polymerase (PARP) inhibitors have shown efficacy in this se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed15150e85f9032caf191f7e19cfc756
https://doi.org/10.1016/s1470-2045(22)00369-2

Zobrazit plný text záznamu

A randomized phase Ib/II study of niraparib (nira) plus nivolumab (nivo) or ipilimumab (ipi) in patients (pts) with platinum-sensitive advanced pancreatic cancer (aPDAC)

Autor: Kim Anna Reiss, Rosemarie Mick, Ursina R. Teitelbaum, Mark H. O'Hara, Charles John Schneider, Ryan Campbell Massa, Thomas Benjamin Karasic, Chioma Onyiah, Mary Kate Gosselin, Alyssa Donze, Susan M. Domchek, Robert H. Vonderheide

Publikováno v: Journal of Clinical Oncology. 40:4021-4021

4021 Background: Establishing alternatives to perpetual chemotherapy for pts with aPDAC has been proposed to address inevitable chemotherapy resistance and cumulative toxicity. Poly (ADP ribose) polymerase (PARP) inhibitors have shown clinical effica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7573a78d12bbadac6d267c5e403a9e5
https://doi.org/10.1200/jco.2022.40.16_suppl.4021

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání